TOKYO, June 1 (Reuters) - Japan's benchmark index ended
slightly lower on Tuesday as investors awaited two key U.S.
economic reports, though declines were capped by hopes of a
domestic economic normalisation on delayed-but-steady rollouts
of COVID-19 vaccines.
The Nikkei share average .N225 inched down 0.16% to close
at 28,814.34, while the broader Topix .TOPX inched up 0.17% to
1,926.18.
"Investors want to confirm the strength of U.S. recovery
from the factory and jobs data to be announced later," said
Masahiro Ichikawa, chief market strategist at Sumitomo Mitsui DS
Asset Management.
U.S. factory activity numbers will be released on Tuesday,
while payrolls data, due on Friday, will be the main event of
the week. Median jobs forecasts are pegged at 650,000, but the
outcome is uncertain following April's unexpectedly weak 266,000
gain.
Among shares and sectors in Japan, steel and drug makers
.ISTEL.T .PHARM.T led the Nikkei's declines, with JFE
Holdings 5411.T falling 4.32% and Nippon Steel 5401.T losing
3.36%.
Daiichi Sankyo 4568.T fell 2.57% and Chugai Pharmaceutical
4519.T lost 1.95%.
IHI 7013.T jumped 5.82% after Nomura Securities changed
its rating for the heavy-industry manufacturer, while its peer
Mitsubishi Heavy Industries 7011.T gained 3.35% after the
brokerage raised its target price.
Renesas Electronics 6723.T gained 3.32% even as the
chipmaker said restoring full production capacity at a
fire-damaged chip plant would take longer than
expected. urn:newsml:reuters.com:*:nT9N2MY020
The stock that gained the most among the top 30 core Topix
names was Toyota Motor 7203.T , up 3.38 %, followed by Murata
Manufacturing 6981.T , which rose 2.05%.
Daiichi Sankyo was the worst performer among the top 30 core
Topix names, followed by Nippon Telegraph and Telephone 9432.T
which lost 1.93%.
(Reporting by Junko Fujita; editing by Uttaresh.V and Devika
Syamnath)
((813-4563-2711, junko.fujita@thomsonreuters.com, Reuters
Messaging:junko.fujita.reuters.com@reuters.net;))